IRCT201112018263N1已完成1 期
evaluating of clobetasol 0.05% and doxepine 5% cream vs clobetasol 0.05% and placebo in the treatment of moderate to severe hand eczema
?Shahid Sadooghi University of Medical Sciences,Yazd0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 70 years（—）
- 性别
- All
入选标准
- •all patients with moderate to severe hand eczema that are 12 to 70 years old
- •exclusion criteria:treatment with systemic steroid less than 1 month before trial;treatment with topical steroid and antihistamines at the time of presentation ;pregnancy;lactatation;age less than 12
排除标准
- 未提供
研究者
相似试验
已完成
1 期
The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult SubjectsHealthyNCT00864240Actavis Inc.15
已完成
不适用
Comparison of efficacy of topical clobetasol 0.05% plus 5FU 5% cream vs. topical clobetasol 0.05% alone in the treatment of vitiligo.Vitiligo.vitiligoIRCT201203049198N2Isfahan Univercity of Medical Sciences45
已完成
2 期
Clobetasol propionate 0.05% versus placebo for the management of erosive oral lichen planusOral lichen planusSkin and Connective Tissue DiseasesISRCTN10647973niversity of Turin (Italy)20
已完成
2 期
Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen PlanusOral Lichen PlanusNCT02744378University of Peradeniya68
进行中（未招募）
不适用
Subject preference comparison between Clobetasol propionate shampoo, 0.05 and three other topical corticosteroids in the treatment of moderate to severe scalp psoriasis - NDScalp PsoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2006-003073-27-ITGALDERMA R D SNC240